DC

Dreavent Capital

North America, Massachusetts, United States, Cambridge

Description

Dreavent Capital is an investment firm focused on Biotech Therapeutics companies.

Investor Profile

Dreavent Capital has made 6 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (50%)
  • Series Unknown (33%)
  • Series B (17%)

Country Focus

  • United States (83%)
  • Spain (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Clinical Trials
  • Personal Health
  • Precision Medicine
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dreavent Capital frequently co-invest with?

Sidecar Angels
North America, Massachusetts, United States, Somerville
Co-Investments: 1
Navis Capital Partners
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Co-Investments: 1
Boston Harbor Angels
North America, Massachusetts, United States, Boston
Co-Investments: 1
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 1
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
DeepWork Capital
North America, Florida, United States, Orlando
Co-Investments: 1
Life Science Angels
North America, California, United States, Sunnyvale
Co-Investments: 1
Alzheimer's Drug Discovery Foundation
North America, New York, United States, New York
Co-Investments: 1
Mid Atlantic Bio Angels
North America, New York, United States, New York
Co-Investments: 1
Mass Medical Angels
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Dreavent Capital often collaborate with?

PR
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Dreavent Capital?

A4CELL

Madrid, Madrid, Spain

A4CELL is a company that develops SPAchip (suspended planar-array chips) that help monitor living single cells.

BiotechnologyLife Science
Series UnknownOct 19, 2023
Amount Raised: $3,175,958
Astrocyte Pharmaceuticals

Cambridge, Massachusetts, United States

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
Series BAug 18, 2023
Amount Raised: $6,000,000
Nido Biosciences

Watertown, Massachusetts, United States

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

BiotechnologyHealth CarePersonal HealthPrecision Medicine
Series ASep 8, 2020
Amount Raised: $18,400,000
Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series ANov 29, 2019
Amount Raised: $15,000,000
Chimeron Bio

Philadelphia, Pennsylvania, United States

Chimeron Bio develops agents for personalized cancer gene therapy.

BiotechnologyHealth CareTherapeutics
Series UnknownJan 1, 2018
Inspirna

New York, New York, United States

Inspirna is a biotechnology company developing drugs for the treatment of cancer.

BiotechnologyHealth CarePharmaceutical
Series AAug 18, 2015
Amount Raised: $8,000,000